Remicade®

BIOLOGICAL2 trials

Sponsors

Biocad

Conditions

Ankylosing SpondylitisRheumatoid Arthritis

Phase 3

Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis

CompletedNCT02762812

BiocadAnkylosing Spondylitis

Start: 2016-01-31End: 2017-07-31Updated: 2018-02-23

Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis

CompletedNCT02762838

BiocadRheumatoid Arthritis

Start: 2016-01-31End: 2018-07-31Updated: 2019-06-14

Related Papers

A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study.

2019-07-107 citations